In particular, they found that 10-mg dosage of tadalafil could reduce the damage of colorectal cancer by 1.7%, and PDE5 inhibitors could be a potential adjuvant drug to improve prognosis for patients with CRC (Huang et al., 2020; Sutton et al., 2020). The gene discussed is PDE5A; the disease is colorectal cancer.